Collectively, estradiol may enhance the body’s anti-tumor immunity by downregulating PD-L1 expression, modulating the population of infiltrating immune cells, and fostering an intestinal microecology that supports immune recovery to counteract the suppressive tumor immune microenvironment (TIME). This evidence concerns the gene CD274 and neoplasm.